GO:0030274 LIM domain binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030274 (LIM domain binding) describes the molecular function of selectively binding to a LIM domain, a zinc-coordinating protein interaction module.
• LIM domains function as modular protein-binding interfaces, and LIM domain binding proteins such as Ldb1 interact with LIM-homeodomain transcription factors to regulate development.
• Competition between LIM-binding domains and other LIM-interacting proteins can modulate transcriptional complex assembly.
• The LIM domain-binding protein Ldb1 binds LIM domains through a conserved mechanism involving the LIM domain's zinc-coordinating structure.
• MICAL proteins are autoinhibited through intramolecular interactions involving their LIM domain, which can be relieved by LIM domain binding.
• Dysregulation of LIM domain-containing proteins and their binding partners is implicated in neurodevelopmental disorders and cancer.
Description
GO:0030274, LIM domain binding, is a molecular function term in the Gene Ontology that describes the selective interaction with a LIM domain, a small zinc-binding module found in many regulatory proteins. LIM domains are composed of two zinc fingers and serve as protein-protein interaction interfaces, allowing LIM domain-containing proteins to assemble into multi-protein complexes that control transcription, cytoskeletal dynamics, and cell signaling. The term is distinct from DNA binding or catalytic activities; it specifically denotes the ability of a protein to recognize and bind the LIM domain fold. Understanding LIM domain binding is critical because it underlies the assembly of key transcriptional complexes, such as those involving LIM-homeodomain proteins and the cofactor Ldb1, which are essential for embryonic development and tissue patterning. Moreover, mutations or dysregulation of LIM domain-containing proteins and their binding partners have been linked to human diseases, including neurodevelopmental syndromes and cancer. Researchers studying these interactions require precise tools to map binding interfaces, quantify affinity, and perturb complex formation in cellular models.
LIM domain binding At A Glance
| GO ID | GO:0030274 |
|---|---|
| GO term | LIM domain binding |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Binding to a LIM domain, a zinc-binding protein interaction module |
| Definition source | QuickGO |
| Domain structure | LIM domain contains seven conserved cysteines and one histidine, binds two zinc ions |
| Representative binding partners | Ldb1, LIM-homeodomain proteins, MICAL |
| Related processes | Transcriptional regulation, cytoskeletal dynamics, cell signaling |
What Is GO:0030274?
LIM domain binding (GO:0030274) is the molecular function of binding to a LIM domain, a protein domain characterized by seven conserved cysteine residues and one histidine that coordinate two zinc ions and act as an interface for protein-protein interactions. This function is mediated by LIM-binding domains (LBDs) or other LIM-interacting motifs that recognize the three-dimensional fold of the LIM domain.
Why Is LIM domain binding Important in Cell Biology?
LIM domain binding is a central mechanism for assembling regulatory protein complexes that control gene expression and cytoskeletal organization. Because LIM domains are found in many transcription factors and signaling proteins, the ability to bind them determines how these proteins partner with cofactors like Ldb1 to regulate developmental and homeostatic programs. Disruption of LIM domain binding can lead to aberrant complex formation, contributing to diseases such as neurodevelopmental disorders and cancer. Thus, studying this function provides insight into both normal biology and disease mechanisms, and it offers targets for therapeutic intervention.
• LIM domain binding mediates the assembly of LIM-homeodomain transcription factor complexes essential for development.
• It provides a mechanism for competition between different LIM-binding proteins, fine-tuning transcriptional output.
• Ldb1 is a key LIM domain-binding protein that interacts with multiple LIM-homeodomain proteins.
• MICAL autoinhibition is regulated by intramolecular interactions involving its LIM domain, which can be modulated by LIM domain binding.
• Dysregulation of LIM domain-containing proteins is associated with neurodevelopmental syndromes such as CHD3-related disorder.
• Circular RNA-mediated regulation of G9a involves LIM domain-containing proteins and contributes to hepatocellular carcinoma metastasis.
• LIM domain binding is a potential target for modulating cytoskeletal dynamics through MICAL proteins.
• Understanding LIM domain binding aids in interpreting disease-associated mutations in LIM domain proteins.
• It enables the design of engineered proteins that can selectively disrupt or enhance complex formation.
• LIM domain binding is relevant to stem cell biology and differentiation due to its role in transcriptional networks.
Molecular Mechanism of LIM domain binding
Recognition of the LIM domain fold
In simple terms: The binding protein recognizes the specific 3D shape of the LIM domain.
LIM domain binding typically involves a LIM-binding domain (LBD) that docks onto the LIM domain's zinc-coordinated structure. The LIM domain itself is a modular protein-binding interface composed of two zinc fingers, and its surface presents a unique topology for interaction. Structural studies of MICAL reveal that its LIM domain participates in autoinhibitory interactions that can be relieved by binding partners.
Competition and complex assembly
In simple terms: Different proteins can compete for the same LIM domain, affecting which complexes form.
Competition between LIM-binding domains and other LIM-interacting proteins can determine the composition of transcriptional complexes. For example, Ldb1 competes with other factors for binding to LIM-homeodomain proteins, thereby influencing gene regulation. This competitive binding is a key regulatory layer in LIM-dependent processes.
Ldb1 as a paradigm of LIM domain binding
In simple terms: Ldb1 is a well-studied protein that binds LIM domains to control gene expression.
Ldb1 interacts with LIM-homeodomain proteins through its LIM domain-binding region, forming complexes that are essential for development. The interaction between Ldb1 and LIM domains is conserved and involves specific residues that recognize the LIM fold. This binding is critical for the transcriptional activity of LIM-homeodomain proteins.
Regulation by autoinhibition and post-translational modifications
In simple terms: Binding can be turned on or off by changes in the binding protein or the LIM domain.
MICAL proteins are autoinhibited by intramolecular interactions involving their LIM domain, and relief of this autoinhibition can be triggered by binding events. Additionally, post-translational modifications or alternative splicing may modulate LIM domain binding, although specific examples remain to be fully defined.
Key Genes Involved in GO:0030274 LIM domain binding
The following genes encode proteins that either contain LIM domains or act as LIM domain-binding partners, and they are frequently studied in the context of GO:0030274.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LDB1 | LIM domain-binding protein 1; binds LIM-homeodomain proteins | Central cofactor in transcriptional complexes; knockout models show developmental defects |
| LDB2 | LIM domain-binding protein 2; paralog of LDB1 | Potential redundant or distinct roles in LIM domain binding |
| LHX1 | LIM-homeodomain transcription factor | Interacts with Ldb1; regulates head development |
| LHX3 | LIM-homeodomain transcription factor | Pituitary development; binds Ldb1 |
| ISL1 | LIM-homeodomain transcription factor | Cardiac and motor neuron development; interacts with Ldb1 |
| MICAL1 | Microtubule-associated monooxygenase | Contains LIM domain; autoinhibition regulated by LIM interactions |
| MICAL2 | MICAL family member | Cytoskeletal regulation; LIM domain involved in autoinhibition |
| MICAL3 | MICAL family member | Role in exocytosis; LIM domain binding potential |
| CHD3 | Chromodomain helicase DNA-binding protein 3 | Mutations cause neurodevelopmental syndrome; may involve LIM domain interactions |
| G9a (EHMT2) | Histone methyltransferase | Regulated by circUBAP2 via LIM domain-containing proteins in HCC |
| PDZD1 | PDZ and homeobox protein domain protein 1 | Transcriptional target in HCC; potential LIM domain crosstalk |
| EIF4A3 | Eukaryotic translation initiation factor 4A3 | Recruited by circRNAs; indirect link to LIM domain protein regulation |
| LIMK1 | LIM kinase 1 | Contains LIM domain; autoregulation via PDZ domain |
| LIMK2 | LIM kinase 2 | Contains LIM domain; regulates actin dynamics |
| ABLIM1 | Actin-binding LIM protein 1 | Cytoskeletal organizer; LIM domains mediate interactions |
| ABLIM2 | Actin-binding LIM protein 2 | Neuronal actin regulation; LIM domain binding |
| ABLIM3 | Actin-binding LIM protein 3 | Cell adhesion and migration; LIM domain interactions |
How Is LIM domain binding Regulated?
LIM domain binding is regulated at multiple levels. Competition between LIM-binding domains and other LIM-interacting proteins can shift complex composition, as shown for Ldb1 and its partners. Autoinhibitory intramolecular interactions, such as those in MICAL proteins, can mask the LIM domain and prevent binding until relieved by conformational changes or post-translational modifications. Additionally, the availability of LIM domain-containing proteins can be controlled by transcriptional regulation, as seen with circUBAP2-mediated stabilization of G9a mRNA in hepatocellular carcinoma. These regulatory layers ensure that LIM domain binding is context-dependent and dynamically controlled.
LIM domain binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CHD3 | Neurodevelopmental syndrome with macrocephaly | Knock-in of patient mutations in iPSC-derived neurons |
| G9a (EHMT2) | Hepatocellular carcinoma metastasis | Knockout in HCC cell lines; overexpression of circUBAP2 |
| MICAL1 | Cytoskeletal dysregulation | Point mutations in LIM domain to disrupt autoinhibition |
| LIMK1 | Neuronal actin dynamics | Knockout and point mutation in PDZ/LIM domains |
| LDB1 | Developmental defects | Conditional knockout in mouse models |
Neurodevelopmental disorders
Mutations in CHD3, a chromatin remodeler, cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language. Although CHD3 does not contain a canonical LIM domain, its interactome may intersect with LIM domain-binding pathways, highlighting the broader relevance of LIM-mediated complexes in brain development.
Cancer
Circular RNA circUBAP2 promotes hepatocellular carcinoma metastasis by increasing G9a stability and repressing PDZD1, a process that involves LIM domain-containing proteins. This illustrates how LIM domain binding and associated regulatory networks can contribute to oncogenesis.
Cytoskeletal and signaling disorders
MICAL proteins, which contain LIM domains, are autoinhibited through intramolecular interactions; dysregulation of this autoinhibition can affect cytoskeletal dynamics and has been implicated in developmental and degenerative conditions. LIM kinases (LIMK1/2) are also regulated by their PDZ domain and LIM domain, impacting actin cytoskeleton and neuronal function.
From LIM domain binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LDB1 disrupt LIM domain binding in development? | Ldb1 knockout mouse or human iPSC-derived organoids |
| How do point mutations in the LIM domain affect binding affinity? | Knock-in of missense mutations in LIM domain genes |
| Can we tag endogenous Ldb1 to track complex assembly? | Knock-in of fluorescent or epitope tags at the LDB1 locus |
| What is the effect of MICAL autoinhibition relief on cytoskeleton? | Overexpression of MICAL mutants lacking autoinhibitory LIM interactions |
| Which genes are regulated by LIM domain binding complexes? | CRISPR knockout of LDB1 followed by RNA-seq |
| Can we screen for modifiers of LIM domain binding? | CRISPR library screening in cells expressing a LIM domain reporter |
How to Study the LIM domain binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Surface plasmon resonance (SPR) | Binding affinity and kinetics | Quantify LIM domain-peptide interactions |
| Isothermal titration calorimetry (ITC) | Thermodynamics of binding | Validate direct binding of Ldb1 to LIM domains |
| X-ray crystallography | Atomic structure of complex | Determine LIM domain-binding interface |
| AP-MS | Protein-protein interactions | Identify endogenous LIM domain interactors |
| Luciferase reporter assay | Transcriptional output | Measure functional consequence of LIM domain binding |
| CRISPR knockout | Loss-of-function phenotype | Study requirement of Ldb1 in LIM-dependent transcription |
| RNA-seq | Global gene expression changes | Identify downstream targets of LIM domain binding complexes |
| Live-cell imaging | Subcellular localization and dynamics | Track LIM domain protein complexes in real time |
Biochemical binding assays
Recombinant LIM domains and candidate binding proteins can be used in pull-down, surface plasmon resonance (SPR), or isothermal titration calorimetry (ITC) to measure affinity and specificity. These methods directly assess the molecular function defined by GO:0030274.
Structural biology
X-ray crystallography or cryo-EM can resolve the interface between a LIM domain and its binding partner, as demonstrated for MICAL autoinhibitory interactions. Such structures reveal the atomic details of LIM domain recognition.
Cell-based reporter assays
Transcriptional reporters driven by LIM-homeodomain complexes can be used to measure the functional impact of LIM domain binding in living cells. Knockdown or knockout of Ldb1 abolishes reporter activity, confirming the role of LIM domain binding.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can identify endogenous proteins that bind to a given LIM domain, providing a comprehensive view of the LIM domain interactome. This approach helps uncover novel LIM domain-binding proteins.
How CRISPR Can Be Used to Study GO:0030274 LIM domain binding
Knockout
CRISPR knockout of genes encoding LIM domain-binding proteins, such as LDB1, can abolish complex formation and reveal downstream transcriptional changes. Knockout models are essential to establish causality in LIM domain binding-dependent processes.
Point Mutation
Introducing point mutations into the LIM domain or the LIM-binding domain can disrupt specific interactions without affecting protein stability. For example, mutations in the LIM domain of MICAL can relieve autoinhibition and alter cytoskeletal dynamics.
Knock-in
Knock-in of epitope tags (e.g., GFP, HA) at endogenous loci allows tracking of LIM domain-binding proteins in their native context. This approach has been used to study Ldb1 complex assembly and localization.
Overexpression
Overexpression of wild-type or mutant LIM domain-containing proteins can drive complex formation or sequester binding partners. Overexpression of MICAL mutants has been used to probe autoinhibition and LIM domain function.
How EDITGENE Supports LIM domain binding Research
Researchers studying LIM domain binding-related genes often need to determine whether a candidate gene is causally involved in complex assembly, transcriptional regulation, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for LIM domain binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| LDB1 Knockout HEK293 Cell Line | EDJ-KQ2801 | Human | 8861 | Details Get a Quote |
| ACTN2 Knockout HEK293 Cell Line | EDJ-KQ3114 | Human | 88 | Details Get a Quote |
| ISL1 Knockout HEK293 Cell Line | EDJ-KQ5008 | Human | 3670 | Details Get a Quote |
| RIPK2 Knockout HEK293 Cell Line | EDJ-KQ6357 | Human | 8767 | Details Get a Quote |
| LDB2 Knockout HEK293 Cell Line | EDJ-KQ6452 | Human | 9079 | Details Get a Quote |
| KAT14 Knockout HEK293 Cell Line | EDJ-KQ11940 | Human | 57325 | Details Get a Quote |
| ISL1 Knockout HCT 116 Cell Line | EDJ-KQ27918 | Human | 3670 | Details Get a Quote |
| ISL1 Knockout HeLa Cell Line | EDJ-KQ27919 | Human | 3670 | Details Get a Quote |
| LDB1 Knockout HeLa Cell Line | EDJ-KQ22372 | Human | 8861 | Details Get a Quote |
| LDB1 Knockout A-549 Cell Line | EDJ-KQ23734 | Human | 8861 | Details Get a Quote |
| LDB1 Knockout HCT 116 Cell Line | EDJ-KQ23735 | Human | 8861 | Details Get a Quote |
| RIPK2 Knockout A-549 Cell Line | EDJ-KQ30314 | Human | 8767 | Details Get a Quote |
| RIPK2 Knockout HCT 116 Cell Line | EDJ-KQ30315 | Human | 8767 | Details Get a Quote |
| RIPK2 Knockout HeLa Cell Line | EDJ-KQ30316 | Human | 8767 | Details Get a Quote |
| KAT14 Knockout A-549 Cell Line | EDJ-KQ40451 | Human | 57325 | Details Get a Quote |
Frequently Asked Questions About LIM domain binding
What is LIM domain binding?
LIM domain binding is the molecular function of selectively interacting with a LIM domain, a zinc-binding protein module that serves as a protein-protein interaction interface.
What genes are involved in LIM domain binding?
Key genes include LDB1, LDB2, LHX1, LHX3, ISL1, MICAL1-3, LIMK1/2, and ABLIM1-3, among others.
What is the GO ID for LIM domain binding?
The Gene Ontology ID for LIM domain binding is GO:0030274.
How does Ldb1 bind to LIM domains?
Ldb1 uses a conserved LIM-binding domain to recognize the zinc-coordinated fold of LIM domains, forming complexes with LIM-homeodomain transcription factors.
What diseases are associated with LIM domain binding?
Dysregulation of LIM domain-containing proteins and their partners has been linked to neurodevelopmental disorders such as CHD3-related syndrome and cancers like hepatocellular carcinoma.
What is the structure of a LIM domain?
A LIM domain contains seven conserved cysteine residues and one histidine that coordinate two zinc ions, forming a compact fold for protein interactions.
How is LIM domain binding regulated?
It can be regulated by competition between binding partners, autoinhibitory intramolecular interactions, and post-translational modifications.
What methods are used to study LIM domain binding?
Common methods include SPR, ITC, X-ray crystallography, AP-MS, reporter assays, and CRISPR-based perturbation.
Can CRISPR be used to study LIM domain binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect LIM domain binding in cells and organisms.
Why is LIM domain binding important for development?
It mediates the assembly of transcriptional complexes that control gene expression programs essential for embryonic development and tissue patterning.
Conclusion
GO:0030274 LIM domain binding is a fundamental molecular function that governs the assembly of protein complexes critical for transcription, cytoskeletal regulation, and development. Its dysregulation is implicated in neurodevelopmental disorders and cancer, making it a compelling area of research. By leveraging CRISPR-based models and biochemical assays, researchers can dissect the precise mechanisms and disease relevance of LIM domain binding.
References
- 1. Matthews JM et al.. 2008. Competition between LIM-binding domains.. Biochem Soc Trans 36(Pt 6):1393-7 PMID: 19021562
- 2. Horvath M et al.. 2024. Structural basis of MICAL autoinhibition.. Nat Commun 15(1):9810 PMID: 39532862
- 3. Agulnick AD et al.. 1996. Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins.. Nature 384(6606):270-2 PMID: 8918878
- 4. Schmeichel KL et al.. 1994. The LIM domain is a modular protein-binding interface.. Cell 79(2):211-9 PMID: 7954790
- 5. Snijders Blok L et al.. 2018. CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language.. Nat Commun 9(1):4619 PMID: 30397230
- 6. Breen JJ et al.. 1998. Interactions between LIM domains and the LIM domain-binding protein Ldb1.. J Biol Chem 273(8):4712-7 PMID: 9468533
- 7. Huang X et al.. 2024. Circ ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 increases the stability of G9a and ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 messenger RNA through recruiting eukaryotic translation initiation factor 4A3, transcriptionally inhibiting PDZ and homeobox protein domain protein 1, and promotes the metastasis of hepatocellular carcinoma.. J Gastroenterol Hepatol 39(3):596-607 PMID: 38059880
- 8. Casanova-Sepúlveda G et al.. 2023. Autoregulation of the LIM kinases by their PDZ domain.. Nat Commun 14(1):8441 PMID: 38114480
